Research Article
A Six-Gene Risk Model Based on the Immune Score Reveals Prognosis in Intermediate-Risk Acute Myeloid Leukemia
Table 1
The clinical characteristics and the immune score/stromal score.
| | Characteristic | Category | Cases | Immune score (median) | Stromal score (median) |
| | Age | <60 years | 45 | 2926.378 | −914.957 | | ≥60 years | 36 | 3233.629 | −826.588 |
| | Gender | Male | 43 | 3031.757 | −881.792 | | Female | 38 | 3106.435 | −925.398 |
| | FAB subtype | M0 | 6 | 3009.567 | −833.614 | | M1 | 21 | 2880.161 | −1033.32 | | M2 | 23 | 2901.244 | −976.13 | | M4 | 18 | 3243.899 | −700.734 | | M5 | 11 | 3274.568 | −677.531 | | M6 | 1 | 3511.771 | −637.973 | | M7 | 1 | 2684.707 | −177.338 |
| | Karyotype | Normal | 68 | 3070.489 | −884.783 | | Others | 3 | 2998.283 | 466.029 | | NA | 10 | — | — |
| | FLT3 gene | Mutant | 25 | 2930.084 | −954.845 | | WT | 46 | 3096.285 | −839.960 | | NA | 10 | — | — |
| | NPM1 gene | Mutant | 28 | 3088.594 | −918.332 | | WT | 43 | 3066.435 | −872.269 | | NA | 10 | — | — |
|
|
